A Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core)

NCT05001373 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

56

Enrollment

NETWORK

Sponsor class

Conditions

Hiv

Interventions

BIOLOGICAL: Core-g28v2 60mer mRNA Vaccine
BIOLOGICAL: eOD-GT8 60mer mRNA Vaccine

Sponsor

International AIDS Vaccine Initiative

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]